Business & Tech
SSF Nonprofit Treats 3rd World Maladies
OneWorld Health develops therapies for diseases where there is none, or where the cost is too high.
A South San Francisco nonprofit drug development organization is using a social enterprise approach to treating global health problems.
The 11-year-old OneWorld Health works with for-profit biotechnology and pharmaceutical companies to develop and distribute drugs to improve the conditions of patients suffering from fatal and often rare diseases.
Internist and CEO Richard Chin describes how OneWorld Health develops new therapies for diseases where there is either no treatment or the cost of treatment is too high in an extended interview with SF Public Press reporter Ambika Kandasamy.
